Free Trial

Lisata Therapeutics (LSTA) SEC Filings & 10K Form

Lisata Therapeutics logo
$2.41 -0.12 (-4.74%)
Closing price 04/29/2025 03:58 PM Eastern
Extended Trading
$2.42 +0.01 (+0.62%)
As of 04/29/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lisata Therapeutics SEC Filings

DateFilerForm TypeView
02/27/2025
3:10 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/23/2025
3:02 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:06 PM
BROWN GREGORY B (Reporting)
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:07 PM
KLOSK STEVEN M (Reporting)
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:08 PM
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Mazzo David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:09 PM
Buck Kristen K (Reporting)
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:10 PM
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Nisco James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
7:33 AM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
4:19 PM
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Nisco James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:21 PM
Buck Kristen K (Reporting)
LISATA THERAPEUTICS, INC. (Issuer)
Lisata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
3:33 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 424B5
08/12/2024
3:21 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:08 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
11:15 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form EFFECT
05/09/2024
3:08 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:02 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/29/2024
3:51 PM
LISATA THERAPEUTICS, INC. (Filer)
Lisata Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LSTA) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners